André Janse

André Janse

Auto-generated profile, based on publicly available information

André Janse

Nutrition & Healthcare Alliance, Ede, the Netherlands

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2018 in Clinical Nutrition
Verified
Journal Article
Closed access
JBJanne Beelen
Janne Beelen
EVEmmelyne Vasse
Emmelyne Vasse
NJNancy Janssen
Nancy Janssen
AJAndré Janse
André Janse
NRNicole M. de Roos
Nicole M. de Roos
CGCornelia De Groot
Cornelia De Groot

12 February 2016 in European Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
AOA. C. B. van Orten-Luiten
A. C. B. van Orten-Luiten
AJA. Janse
A. Janse
RDRosalie Dhonukshe-Rutten
Rosalie Dhonukshe-Rutten
RWRenger Witkamp
Renger Witkamp
Purpose Adverse drug reactions as well as vitamin D deficiency are issues of public health concern in older people. However, relatively little is known about the impact of drug use on vitamin D status. Our primary aim is to explore associations between drug use and vitamin D status in older people. Furthermore, prevalences of drug use and vitamin D deficiency are estimated. Methods In a population of 873 community-dwelling Dutch geriatric outpatients, we explored the cross-sectional relationships of polypharmacy (≥5 medications concomitantly used), severe polypharmacy (≥10 medications), and use of twenty-one specific drug groups, with serum 25-hydroxyvitamin D (25(OH)D) by analysis of covariance. Results Overall prevalence of polypharmacy was 65 %, of severe polypharmacy 22 %. Depending on the cut-off value, prevalence of vitamin D deficiency was 49 % (<50 nmol/l) or 77 % (<75 nmol/l). Of the patients using a vitamin D supplement, 17 % (<50 nmol/l) or 49 % (<75 nmol/l) were still deficient. In non-users of supplemental vitamin D, after adjustment for age and gender, negative associations were found for severe polypharmacy, metformin, sulphonamides and urea derivatives (SUDs), vitamin K antagonists, cardiac glycosides, loop diuretics, potassium-sparing diuretics, ACE inhibitors, and serotonin reuptake inhibitors; for non-selective monoamine reuptake inhibitors (NSMRIs) the association was positive. The most extreme impacts of drug use on adjusted mean 25(OH)D were −19 nmol/l for SUDs and +18 nmol/l for NSMRIs. Conclusion Drug use should be considered a risk factor for vitamin D deficiency amongst geriatric outpatients.

1 December 2019 in Clinical Nutrition
Verified
Journal Article
Closed access
AOA.C.B. van Orten-Luiten
A.C.B. van Orten-Luiten
AJA. Janse
A. Janse
EVE. Verspoor
E. Verspoor
EBElske Brouwer-Brolsma
Elske Brouwer-Brolsma
RWRenger Witkamp
Renger Witkamp

15 August 2009 in The Primary Care Companion For CNS Disorders
Verified
Journal Article
Open access
AJAndré Janse
André Janse
RMRadboud M. Marijnissen
Radboud M. Marijnissen

1 August 2025 in European Journal of Clinical Pharmacology
Verified
Journal Article
Open access
PDF file
AOAnne Claire B. van Orten-Luiten
Anne Claire B. van Orten-Luiten
EBElske Brouwer-Brolsma
Elske Brouwer-Brolsma
AJAndré Janse
André Janse
RWRenger Witkamp
Renger Witkamp
Purpose: Chronic hyponatremia in older people is associated with adverse outcomes including gait disturbances, falls, osteoporosis, fractures, cognitive impairment, and cardiovascular disease. Diagnosis in outpatient settings is challenging due to the non-specific nature of its symptoms. While hyponatremia is well-studied in hospitalized patients, little research has focused on outpatient settings. This study aimed to develop a drug-based model to non-invasively predict hyponatremia in older adults attending a geriatric outpatient clinic. Methods: Cross-sectional data from 2181 outpatients aged ≥ 55 were analysed using logistic regression. Polypharmacy, 27 specific drug groups, sex, age, and BMI were considered as potential risk factors. Predictors were selected using stepwise backward logistic regression for the complex model and LASSO regression for the simple model. Internal validation was performed through bootstrapping, and model performance was evaluated by constructing a receiver operating characteristic (ROC) curve. Results: The prevalence of hyponatremia was 10.5%, with higher occurrence in women. The complex model identified predictors including sex, age, BMI, polypharmacy, and 11 drug groups, achieving an area under the curve (AUC) of 0.75, [95% CI 0.72–0.79], indicating a reasonably good ability to distinguish between hypo- and normonatremia. The simple model, including only polypharmacy, had limited predictive performance (AUC = 0.64 [95% CI 0.60–0.68]). Conclusion: The complex, drug-based model predicts hyponatremia risk in outpatients of a geriatric clinic. Timely recognition may prevent inappropriate treatments for undiagnosed cases and associated harms. The model merits further development for clinical use.

1 September 2013 in European Geriatric Medicine
Verified
Journal Article
Closed access
AOA.C.B. van Orten-Luiten
A.C.B. van Orten-Luiten
AJA. Janse
A. Janse
RDR.A.M. Donukshe-Rutten
R.A.M. Donukshe-Rutten
RWR.F. Witkamp
R.F. Witkamp